332 related articles for article (PubMed ID: 22833959)
1. Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review.
Bhattacharjee H; Balabathula P; Wood GC
Ther Deliv; 2010 Nov; 1(5):713-34. PubMed ID: 22833959
[TBL] [Abstract][Full Text] [Related]
2. Dendronized Systems for the Delivery of Chemotherapeutics.
Dockery L; Daniel MC
Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Threatening cancer with nanoparticle aided combination oncotherapy.
Rawal S; Patel MM
J Control Release; 2019 May; 301():76-109. PubMed ID: 30890445
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
6. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-based targeted drug delivery.
Singh R; Lillard JW
Exp Mol Pathol; 2009 Jun; 86(3):215-23. PubMed ID: 19186176
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine in cancer therapy: innovative trends and prospects.
Blanco E; Hsiao A; Mann AP; Landry MG; Meric-Bernstam F; Ferrari M
Cancer Sci; 2011 Jul; 102(7):1247-52. PubMed ID: 21447010
[TBL] [Abstract][Full Text] [Related]
9. Polymer- and liposome-based nanoparticles in targeted drug delivery.
Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
[TBL] [Abstract][Full Text] [Related]
10. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
11. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
Wang J; Sui M; Fan W
Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
[TBL] [Abstract][Full Text] [Related]
15. Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review.
Yu Z; Yan B; Gao L; Dong C; Zhong J; D Ortenzio M; Nguyen B; Seong Lee S; Hu X; Liang F
Curr Cancer Drug Targets; 2016; 16(6):509-21. PubMed ID: 26632436
[TBL] [Abstract][Full Text] [Related]
16. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
Ahmed SE; Martins AM; Husseini GA
J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
[TBL] [Abstract][Full Text] [Related]
17. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
Cao J; Huang D; Peppas NA
Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy.
O'Neill CP; Dwyer RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32102476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
